HIGHLIGHTS
- who: BRCA and colleagues from the CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France have published the paper: the Treatment of Early Breast Cancer: The Step Beyond?, in the Journal: (JOURNAL)
- what: The I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response Through Imaging and Molecular AnaLysis 2, I-SPY 2) was an adaptive randomized phase II study aiming to evaluate various innovative therapeutic compounds in the neoadjuvant setting, in specific subsets of BC defined by combining the expression of HER2 and hormone_receptors, with the Mammaprint signature . The aim . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.